Single-Arm Studies Can Have Adaptive Designs, Industry Tells FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA's recent draft guidance on adaptive device trial designs is a good step, but it should be more inclusive of single-arm studies and not just randomized trials, AdvaMed says.